Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thymosin beta 15a pseudogene (ENSG00000250650) is a processed pseudogene related to the functional TMSB15A gene, which encodes thymosin beta 15, a 5 kDa actin-binding protein involved in cell motility and actin dynamics[1]. However, this pseudogene has been characterized as non-coding due to loss of coding potential: it contains frameshift mutations, stop codons, and codon deletions that prevent translation into a functional protein[1][3]. The presence of this pseudogene in the human genome likely reflects past gene duplication and retrotransposition events, but it does not itself represent a therapeutic target, nor does it have established biological or pharmacological functions. Key context and justification: - Thymosin beta 15a pseudogene is clearly distinguished from functional genes like TMSB15A and TMSB15B, which encode active proteins linked to cancer cell motility, immune function, and actin dynamics[1][2]. - Unlike these protein-coding genes, the pseudogene lacks the potential to generate a protein due to disruptive mutations[1][3]. - There is no evidence in the literature or databases that the pseudogene is a therapeutic target, is involved in disease mechanisms, or interacts with any drugs. Incorrectness note: The requested target, "thymosin beta 15a pseudogene," is not itself a targetable molecule or receptor—rather, it is a non-functional, processed pseudogene. If a functional target is intended, the focus should shift to TMSB15A or TMSB15B (thymosin beta 15 A/B), which are protein-coding genes involved in actin regulation, cancer cell migration, and thymic epithelial cell biology[1][2][4]. If you require details for the protein-coding gene (TMSB15A or TMSB15B) rather than the pseudogene, please clarify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thymosin beta 15a pseudogene.